Bioxytran BIXT Stock
Bioxytran Price Chart
Bioxytran BIXT Financial and Trading Overview
| Bioxytran stock price | 0.03 USD |
| Previous Close | 0.03 USD |
| Open | 0.03 USD |
| Bid | 0.03 USD x 2300000 |
| Ask | 0.03 USD x 1000000 |
| Day's Range | 0.03 - 0.03 USD |
| 52 Week Range | 0.03 - 0.15 USD |
| Volume | 30K USD |
| Avg. Volume | 306.64K USD |
| Market Cap | 3.71M USD |
| Beta (5Y Monthly) | 1.958 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BIXT Valuation Measures
| Enterprise Value | 4.5M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -1.381 |
Trading Information
Bioxytran Stock Price History
| Beta (5Y Monthly) | 1.958 |
| 52-Week Change | -76.76% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 0.15 USD |
| 52 Week Low | 0.03 USD |
| 50-Day Moving Average | 0.04 USD |
| 200-Day Moving Average | 0.06 USD |
BIXT Share Statistics
| Avg. Volume (3 month) | 306.64K USD |
| Avg. Daily Volume (10-Days) | 30K USD |
| Shares Outstanding | 114.2M |
| Float | 113.48M |
| Short Ratio | N/A |
| % Held by Insiders | 0.62% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -544.42% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -3260420 USD |
| Net Income Avi to Common (ttm) | -2838431 USD |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 463.05K USD |
| Total Cash Per Share (mrq) | 0.004 USD |
| Total Debt (mrq) | 1.21M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.092 |
| Book Value Per Share (mrq) | -0.039 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -597742 USD |
| Levered Free Cash Flow (ttm) | 1.49M USD |
Profile of Bioxytran
| Country | United States |
| State | MA |
| City | Needham |
| Address | 75 2nd Avenue |
| ZIP | 02494 |
| Phone | 617 454 1199 |
| Website | https://www.bioxytraninc.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 2 |
Bioxytran, Inc., a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address viral infections, glycovirology, and oxygen delivery, hypoxia and degenerative diseases in humans. The company's lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for use in the treatment of hypoxic conditions in the brain resulting from stroke, and hypoxic conditions in wounds to prevent necrosis and to promote healing. It is also developing ProLectin, a polysaccharide derived from pectin that binds to, and blocks the activity of galectin-3, a type of galectin for treatment of mild to moderate cases of Covid-19. Bioxytran, Inc. has collaboration with University of Minnesota for advance novel carbohydrate-based therapeutics. The company was founded in 2008 and is headquartered in Needham, Massachusetts.
Q&A For Bioxytran Stock
What is a current BIXT stock price?
Bioxytran BIXT stock price today per share is 0.03 USD.
How to purchase Bioxytran stock?
You can buy BIXT shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bioxytran?
The stock symbol or ticker of Bioxytran is BIXT.
Which industry does the Bioxytran company belong to?
The Bioxytran industry is Biotechnology.
How many shares does Bioxytran have in circulation?
The max supply of Bioxytran shares is 114.2M.
What is Bioxytran Price to Earnings Ratio (PE Ratio)?
Bioxytran PE Ratio is now.
What was Bioxytran earnings per share over the trailing 12 months (TTM)?
Bioxytran EPS is -0.02 USD over the trailing 12 months.
Which sector does the Bioxytran company belong to?
The Bioxytran sector is Healthcare.